dalteparin has been researched along with Deficiency Disease, Ornithine Carbamoyltransferase in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venkateswaran, L | 1 |
| Scaglia, F | 1 |
| McLin, V | 1 |
| Hertel, P | 1 |
| Shchelochkov, OA | 1 |
| Karpen, S | 1 |
| Mahoney, D | 1 |
| Yee, DL | 1 |
1 other study available for dalteparin and Deficiency Disease, Ornithine Carbamoyltransferase
| Article | Year |
|---|---|
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis.
Topics: Anticoagulants; Compartment Syndromes; Enoxaparin; Humans; Infant; Infant, Newborn; Male; Ornithine | 2009 |